Screen › Candidate profiles › EXEL
Exelixis Inc (EXEL) — wheel strategy suitability
Where EXEL sits as an underlying for selling cash-secured puts and covered calls, and what its own price history says about the risk of being assigned into a falling stock. Snapshot of 3 October 2026.
Exelixis Inc (EXEL) scores 69 on the Wheel score, which puts it in the acceptable band — it passes the profitability and options filters but is not among the strongest candidates.
The score is carried by its quality (88/100) and held back by valuation (36/100). Growth is deliberately excluded from this score: fast growers tend to carry high implied volatility and gap risk, which is the opposite of what a wheel seller wants. It is not cheap, so assignment would leave you holding a fully priced stock.
It has monthly options only, which costs it a small liquidity haircut. Workable, but every roll commits you for a month.
Over the last 3.0 years it had 2 days with a fall of 10% or more (0.67 a year), a deepest drawdown of -25.3%, and a worst single session of -16.8%. That is in line with the median screened name (0.67 gap-downs a year, -44.9% typical worst drawdown).
Realised volatility runs about 38% annualised. That sits in the range where premium is worth collecting without the stock being wild.
Score breakdown
| Wheel score | 69 | 0–100 suitability for options selling |
|---|---|---|
| Quality | 88 | ROIC, margins, leverage, accruals |
| Valuation | 36 | cheaper on fwd P/E, EV/EBITDA, FCF yield |
| Margin stability | — | steadier earnings score higher |
| Options listed | Monthly | weekly avoids the liquidity haircut |
| Accounting flags | 0 | −8 points each |
Realised tail risk
Computed from our own daily price history, 2023-10-04 to 2026-10-01 (749 sessions). The Wheel score is built from fundamentals, so these price-derived numbers are an independent check on it, not a restatement of it.
| Days falling 10%+ in one session | 2 | 0.67 a year |
|---|---|---|
| Deepest drawdown | -25.3% | peak to trough |
| Worst single session | -16.8% | |
| Realised volatility | 38% | annualised |
Fundamentals
| Revenue (ttm) | 2,320M USD |
|---|---|
| Revenue CAGR (3y) | 12.9% |
| Net margin | 33.7% |
| Return on equity | 36.2% |
| Share price | $57.94 |
| Days to earnings | — |
| Sector / industry | Healthcare · Biotechnology |
Open the EXEL options chain on Yahoo Finance to check live strikes and premium — this page deliberately carries no quotes, because a quote baked into a static page is stale before you read it.
Run the numbers on EXEL
Pre-filled with the snapshot price of $57.94 and 30-day realised volatility; add the strike and premium from the live option chain.